Mechanisms of Telomere-Mediated Lung Disease
Mechanisms of Telomere-Mediated Lung Disease
批准号:
10445011
负责人:
Jonathan K. Alder
金额:
$38.44万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-07-10 至 2023-06-30
关键词:
AddressAdultAffectAgeAgingAlveolarAnimal ModelApoptosisBiological ClocksBiologyCause of DeathCell AgingCell Cycle ArrestCell ProliferationCellsCessation of lifeChromosomesChronicChronic Obstructive Pulmonary DiseaseClinicalCountryDNADNA DamageDataDiseaseElderlyEpithelialEpithelial CellsFailureFunctional disorderGenesGeneticHealthcareHealthcare SystemsHeartIn VitroInflammationInflammatoryInflammatory ResponseLeadLeftLinkLiverLungLung TransplantationLung diseasesMediatingMetabolicMitochondriaModelingMolecularMorphologyMusMutationNatural regenerationOrganOxidation-ReductionOxidative StressPathogenesisPhenotypePneumonectomyPositioning AttributeProteinsPulmonary EmphysemaRecoveryRegulationRisk FactorsRoleSamplingSerumSignal TransductionTelomeraseTelomere MaintenanceTelomere Maintenance GeneTelomere ShorteningTestingTherapeutic InterventionTimeTissuesToxinUnited StatesWorkalveolar epitheliumcell typeearly onsetendoplasmic reticulum stressextracellularidiopathic pulmonary fibrosisin vivolung injurylung regenerationlung repairmitochondrial dysfunctionmouse modelmutation carriernovelnovel strategiespreventprogenitorrepairedrespiratoryresponsesenescencestemstem cellssurfactanttelomeretissue repair
中文摘要
摘要
英文摘要
Abstract
Age associated lung diseases, including chronic obstructive pulmonary disease (COPD) and idiopathic
pulmonary fibrosis (IPF), are devastating diseases that limit respiratory capacity and are responsible for an
enormous burden on our country’s health care system. There are essentially no treatments for these diseases
except for lung transplantation. Advanced age is a significant risk factors for COPD and PF yet how it
contributes to disease pathogenesis is not known. Recently, mutations in the genes responsible for telomere
maintenance have been recognized as the most common identifiable cause of IPF and a significant fraction
COPD. This discovery provides a new framework for understanding lung disease and may provide a link to
aging.
Telomeres are DNA-protein caps on the ends of each of chromosomes that function as biologic clocks.
Telomeres shorten with age and when they become too short, they trigger cellular senescence (permanent cell
cycle arrest) or death. Unexpectedly, the lung is the organ most frequently affected by short telomeres and the
mechanisms that lead to lung disease are not known. We have developed a novel mouse model that permits
induction of telomere dysfunction in specific cell-types within the lung. When triggered, telomere failure leads to
senescence, rather than apoptosis, in lung epithelial cells. Because the fraction of senescent cells increases as
we age, this model provides an opportunity to examine the consequences of aging in specific cells and tissues.
This proposal aims to explore the mechanisms by which telomeres dysfunction and subsequent cellular
senescence cause lung disease. We will dissect the consequences of cellular senescence in three related
aims. In each aim, we examine different aspects of cellular senescence on lung biology. In Aim 1, we will
investigate the consequences of inhibited cell proliferation on lung epithelial cells and examine if they can
contribute to lung regeneration after pneumonectomy. In Aim 2, we will characterize proteins that are secreted
by senescent epithelial cells and determine their role in chronic inflammation. We will also test if they are
present in clinical IPF samples. Finally, in Aim 3, we will determine if telomere dysfunction and senescence are
sufficient to cause mitochondrial dysfunction in the lung epithelium. We hope that these data will not only
contribute to our understanding of lung disease, but also suggest novel approaches to treating it.
期刊论文(12)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1002/cbin.10952
发表时间:
2018-07
期刊:
Cell biology international
影响因子:
3.9
作者:
[Ringer KP, Roth MG, Garey MS, Piorczynski TB, Suli A, Hansen JM, Alder JK]
通讯作者:
Alder JK
DOI:
10.3389/fmed.2021.600626
发表时间:
2021
期刊:
Frontiers in medicine
影响因子:
3.9
作者:
[Sullivan DI, Jiang M, Hinchie AM, Roth MG, Bahudhanapati H, Nouraie M, Liu J, McDyer JF, Mallampalli RK, Zhang Y, Kass DJ, Finkel T, Alder JK]
通讯作者:
Alder JK
Lung transplant recipients with telomere-mediated pulmonary fibrosis have increased risk for hematologic complications.
患有端粒介导的肺纤维化的肺移植受者发生血液学并发症的风险增加。
DOI:
10.1016/j.ajt.2023.06.014
发表时间:
2023
期刊:
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
影响因子:
--
作者:
[Hannan,StefanieJ, Iasella,CarloJ, Sutton,RachelM, Popescu,IuliaD, Koshy,Ritchie, Burke,Robin, Chen,Xiaoping, Zhang,Yingze, Pilewski,JosephM, Hage,ChadiA, Sanchez,PabloG, Im,Annie, Farah,Rafic, Alder,JonathanK, McDyer,JohnF]
通讯作者:
McDyer,JohnF
DOI:
10.1111/ajt.15756
发表时间:
2020-05
期刊:
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
影响因子:
--
作者:
[Iasella CJ, Winters SA, Kois A, Cho J, Hannan SJ, Koshy R, Moore CA, Ensor CR, Lendermon EA, Morrell MR, Pilewski JM, Sanchez PG, Kass DJ, Alder JK, Nouraie SM, McDyer JF]
通讯作者:
McDyer JF
DOI:
10.1002/humu.24476
发表时间:
2022-12
期刊:
HUMAN MUTATION
影响因子:
3.9
作者:
[Sutton, Rachel M., Bittar, Humberto Trejo, Sullivan, Daniel, I, Silva, Agustin Gil, Bahudhanapati, Harinath, Parikh, Anishka H., Zhang, Yingze, Gibson, Kevin, McDyer, John F., Kass, Daniel J., Alder, Jonathan K.]
通讯作者:
Alder, Jonathan K.
共 7 条
The Role of Telomeres in Lung Transplant Recipient Immunity and Outcomes
-
批准号:10561968
-
项目类别:
-
资助金额:$72.35万
-
财政年份:2023
-
负责人:Jonathan K. Alder
-
依托单位:
Mechanisms of Telomere-Mediated Lung Disease
-
批准号:10206235
-
项目类别:
-
资助金额:$38.44万
-
财政年份:2018
-
负责人:Jonathan K. Alder
-
依托单位:
Mechanisms of Teleomere-Mediated Emphysema
-
批准号:8819562
-
项目类别:
-
资助金额:$24.53万
-
财政年份:2014
-
负责人:Jonathan K. Alder
-
依托单位:
Mechanisms of Teleomere-Mediated Emphysema
-
批准号:9752945
-
项目类别:
-
资助金额:$12.28万
-
财政年份:2014
-
负责人:Jonathan K. Alder
-
依托单位:
Mechanisms of Teleomere-Mediated Emphysema
-
批准号:8803454
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2014
-
负责人:Jonathan K. Alder
-
依托单位:
Mechanisms of Teleomere-Mediated Emphysema
-
批准号:9081635
-
项目类别:
-
资助金额:$12.62万
-
财政年份:2014
-
负责人:Jonathan K. Alder
-
依托单位:
Mechanisms of Teleomere-Mediated Emphysema
-
批准号:8484871
-
项目类别:
-
资助金额:$13.68万
-
财政年份:2012
-
负责人:Jonathan K. Alder
-
依托单位:
Mechanisms of Teleomere-Mediated Emphysema
-
批准号:8280746
-
项目类别:
-
资助金额:$13.64万
-
财政年份:2012
-
负责人:Jonathan K. Alder
-
依托单位:
海外基金